Our findings showed that SLC2A1 is positively correlated with CD8+ T cells in some cancer types, but negatively correlated in other cancer types, suggesting that the effect of SLC2A1 on CD8+ T cells in the TME is complex. The gene discussed is CD8A; the disease is cancer.